1. Correction: Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach
- Author
-
Maria Elena Romero-Ibarguengoitia, Ravindranath Duggirala, Isabel Ibarra-González, María Fabiola Serratos-Canales, Mireya León-Hernández, Felipe Vadillo-Ortega, Arturo Herrera-Rosas, Augusto Enrique Caballero, Antonio González-Chávez, Srinivas Mummidi, and Juan Carlos López-Alvarenga
- Subjects
0301 basic medicine ,Adult ,Male ,Adolescent ,lcsh:Medicine ,030209 endocrinology & metabolism ,Disease ,Bioinformatics ,Models, Biological ,Structural equation modeling ,03 medical and health sciences ,0302 clinical medicine ,Metabolomics ,Non-alcoholic Fatty Liver Disease ,Carnitine ,medicine ,Humans ,Obesity ,Family history ,Amino Acids ,lcsh:Science ,Medical History Taking ,Multidisciplinary ,business.industry ,lcsh:R ,Fatty liver ,Correction ,Non alcoholic ,Middle Aged ,medicine.disease ,030104 developmental biology ,Cross-Sectional Studies ,Diabetes Mellitus, Type 2 ,lcsh:Q ,Female ,business - Abstract
Structural equation modeling (SEM) can help understanding complex functional relationships among obesity, non-alcoholic fatty liver disease (NAFLD), family history of obesity, targeted metabolomics and pro-inflammatory markers. We tested two hypotheses: 1) If obesity precedes an excess of free fatty acids that increase oxidative stress and mitochondrial dysfunction, there would be an increase of serum acylcarnitines, amino acids and cytokines in obese subjects. Acylcarnitines would be related to non-alcoholic fatty disease that will induce insulin resistance. 2) If a positive family history of obesity and type 2 diabetes are the major determinants of the metabolomic profile, there would be higher concentration of amino acids and acylcarnitines in patients with this background that will induce obesity and NAFLD which in turn will induce insulin resistance.137 normoglycemic subjects, mean age (SD) of 30.61 (8.6) years divided in three groups: BMI25 with absence of NAFLD (G1), n = 82; BMI30 with absence of NAFLD (G2), n = 24; and BMI30 with NAFLD (G3), n = 31. Family history of obesity (any) was present in 53%. Both models were adjusted in SEM. Family history of obesity predicted obesity but could not predict acylcarnitines and amino acid concentrations (effect size0.2), but did predict obesity phenotype.Family history of obesity is the major predictor of obesity, and the metabolic abnormalities on amino acids, acylcarnitines, inflammation, insulin resistance, and NAFLD.
- Published
- 2018